Mechanisms of ascites formation.

Abstract:

:Ascites is the most common complication of cirrhosis. It is associated with profound changes in the splanchnic and systemic circulation and with renal abnormalities. The development of ascites is related to the existence of severe sinusoidal portal hypertension that causes marked splanchnic arterial vasodilation and a forward increase in the splanchnic production of lymph. Splanchnic arterial vasodilation also produces arterial vascular underfilling, arterial hypotension, compensatory activation of the RAAS, SNS, and AVP, and a continuous sodium and water retention, leading to ascites formation. Now, therefore, the splanchnic arterial circulation, rather than the venous portal system, is believed to be involved in the pathogenesis of ascites formation.

journal_name

Clin Liver Dis

journal_title

Clinics in liver disease

authors

Cárdenas A,Bataller R,Arroyo V

doi

10.1016/s1089-3261(05)70118-5

subject

Has Abstract

pub_date

2000-05-01 00:00:00

pages

447-65

issue

2

eissn

1089-3261

issn

1557-8224

pii

S1089-3261(05)70118-5

journal_volume

4

pub_type

杂志文章,评审
  • Nonviral or Drug-Induced Etiologies of Acute Liver Failure.

    abstract::Acute liver failure (ALF) is a rare but highly fatal condition. The most common causes include drug-induced and viral hepatitis, but other less common etiologies, especially autoimmune hepatitis, Budd-Chiari syndrome, and Wilson disease, need to be considered. Because diagnosis is frequently tied to potential for reve...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.01.008

    authors: Rosenblatt R,Brown RS Jr

    更新日期:2018-05-01 00:00:00

  • Management of nonalcoholic fatty liver disease: weight control.

    abstract::With obesity reaching epidemic proportions in the United States, it is imperative that hepatologists have an understanding of the medical ramifications and methods of treatment. Evaluation of nonalcoholic fatty liver disease may get the patient into the office,but weight reduction may provide a therapeutic hurdle. Thi...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.04.003

    authors: Bouneva I,Kirby DF

    更新日期:2004-08-01 00:00:00

  • Recent developments in the pathophysiology of cholestasis.

    abstract::The past decade has brought tremendous growth in the under-standing of the pathophysiologic mechanisms involved in cholestasis, both at the genetic and acquired levels. The discovery and characterization of an array of hepatobiliary transport proteins, the nuclear receptors that regulate them, and the potential clinic...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/S1089-3261(03)00125-9

    authors: Hutchins GF,Gollan JL

    更新日期:2004-02-01 00:00:00

  • Management of renal dysfunction in patients receiving a liver transplant.

    abstract::Renal dysfunction is a frequent complication in patients with endstage liver disease awaiting orthotopic liver transplantation. Although the stereotypical form of renal dysfunction is the hepatorenal syndrome, common causes of acute kidney injury include prerenal azotemia and acute tubular necrosis in this population....

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2011.08.001

    authors: Lau C,Martin P,Bunnapradist S

    更新日期:2011-11-01 00:00:00

  • Hepatic granulomas and hepatic sarcoidosis.

    abstract::The causes of hepatic granulomas are numerous and their identification can be difficult. Sarcoidosis is a main cause of hepatic granulomas. The mechanisms that initiate the formation of sarcoid granulomas are unknown. This article discusses the pathology of hepatic sarcoidosis and hepatic granulomas. ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70108-2

    authors: Valla DC,Benhamou JP

    更新日期:2000-02-01 00:00:00

  • Liver transplant and recurrent disease.

    abstract::Current prophylactic measures have greatly reduced recurrence rates of hepatitis B after liver transplantation. HBIG remains a critically important compound and although there is variability in dosing regimens and target anti-HBs levels, it is the backbone of recurrence prevention. Adjuvant therapies with nucleoside/n...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.02.011

    authors: Poordad FF

    更新日期:2004-05-01 00:00:00

  • Autoimmune hepatitis and overlap syndromes.

    abstract::Autoimmune hepatitis (AIH) is an immune-mediated, autodestructive liver disease with hepatocytes as target cells, mostly affecting young women. Primary biliary cirrhosis (PBC) is also regarded as an autoimmune liver disease with bile duct epithelia as the target cells, resulting in a continuous loss of bile ducts. Bot...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00007-7

    authors: Dienes HP,Erberich H,Dries V,Schirmacher P,Lohse A

    更新日期:2002-05-01 00:00:00

  • Issues unique to pediatric liver transplantation.

    abstract::Liver transplantation in pediatrics has become an accepted modality of treatment in end-stage liver disease and irreversible acute liver failure. Biliary atresia is the most common indication requiring liver transplantation in children. The diagnosis and causes of acute liver failure in children differ from those in a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2007.04.001

    authors: Kerkar N,Emre S

    更新日期:2007-05-01 00:00:00

  • The Pathology of Alcoholic Liver Disease.

    abstract::The term "alcoholic liver disease" encompasses a spectrum of pathologic conditions ranging from isolated steatosis to established cirrhosis. Within this spectrum, varying degrees of inflammation, hepatocellular ballooning degeneration, hepatocyte necrosis, cholestasis, and fibrosis may be encountered. This article rev...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.02.006

    authors: Alpert L,Hart J

    更新日期:2016-08-01 00:00:00

  • The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.

    abstract::Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that can be divided into benign steatosis or nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Elastography and scoring systems based on clinical features and routine biochemical testing can be used to assess fibrosis in patient...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.08.006

    authors: Gunn NT,Shiffman ML

    更新日期:2018-02-01 00:00:00

  • Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis.

    abstract::A human betaretrovirus has been characterized in patients with primary biliary cirrhosis (PBC) and the related mouse mammary tumor virus linked with autoimmune biliary disease in the NOD.c3c4 mouse model. Translational studies have been performed in patients who have PBC to investigate the role of viral infection in d...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2008.02.006

    authors: Mason AL,Wasilenko ST

    更新日期:2008-05-01 00:00:00

  • Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy.

    abstract::Both covert hepatic encephalopathy (CHE) and overt hepatic encephalopathy (OHE) impair the ability to operate machinery. The legal responsibilities of US physicians who diagnose and treat patients with hepatic encephalopathy vary among states. It is imperative that physicians know the laws regarding reporting in their...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.04.004

    authors: Vierling JM

    更新日期:2015-08-01 00:00:00

  • Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.

    abstract::Although there are no randomized, controlled trials evaluating the efficacy of endoscopic retrograde cholangiography (ERC) in primary sclerosing cholangitis (PSC) patients, substantial indirect evidence supports the effectiveness of ERC in symptomatic PSC patients with a dominant stricture. Currently, cumulative evide...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2014.07.013

    authors: Thosani N,Banerjee S

    更新日期:2014-11-01 00:00:00

  • Hepatobiliary manifestations of critically ill and postoperative patients.

    abstract::Liver dysfunction is common in both the critically ill and postoperative patient. Metabolic derangements secondary to sepsis, poor hepatic perfusion, total parenteral nutrition, in addition to hemodynamic and anesthetic-induced changes that occur during surgery, can cause liver damage ranging from small self-limited a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.09.004

    authors: Aronsohn A,Jensen D

    更新日期:2011-02-01 00:00:00

  • Viral Hepatitis Other than A, B, and C: Evaluation and Management.

    abstract::Viral hepatitis can cause a wide spectrum of clinical presentations from a benign form with minimal or no symptoms to acute liver failure or death. Hepatitis D coinfection and superinfection have distinct clinical courses, with the latter more likely leading to chronic infection. Management of chronic hepatitis D viru...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2020.04.008

    authors: Cheung A,Kwo P

    更新日期:2020-08-01 00:00:00

  • Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

    abstract::Nonsteroidal anti-inflammatory drugs are among the most common drugs associated with drug-induced liver injury, with an estimated incidence of between 3 and 23 per 100,000 patient years. Nimesulide, sulindac, and diclofenac seem to be associated with the highest risk and the only risk factor consistently identified is...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2007.06.004

    authors: Aithal GP,Day CP

    更新日期:2007-08-01 00:00:00

  • Capsule endoscopy in portal hypertension.

    abstract::Since the introduction of small bowel capsule endoscopy, and more recently of esophageal capsule endoscopy, these diagnostic tools have become available for the evaluation of the consequences of portal hypertension in the esophagus, stomach, and small intestine. The main advantage of the esophageal and the small bowel...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.03.004

    authors: Rondonotti E,Villa F,Dell' Era A,Tontini GE,de Franchis R

    更新日期:2010-05-01 00:00:00

  • Health care-associated transmission of hepatitis B and C viruses in endoscopy units.

    abstract::The risk for potential transmission of infectious agents during gastrointestinal (GI) endoscopy is concerning for patients and physicians. However, the instance of infection transmission remains rare after GI endoscopy procedures, with an estimated frequency of 1 in 1.8 million procedures. Endoscopy-related infection ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2009.11.012

    authors: Wu H,Shen B

    更新日期:2010-02-01 00:00:00

  • Acute liver failure: a review.

    abstract::Since publication of the first descriptions of acute liver failure (ALF) as a distinct clinical entity in the 1950's, the understanding of the pathophysiologic mechanisms involved and the management options have increased substantially. ALF still represents a major challenge for todays hepatologists, because it can ra...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2006.05.010

    authors: Khan SA,Shah N,Williams R,Jalan R

    更新日期:2006-05-01 00:00:00

  • Cholestatic liver disease overlap syndromes.

    abstract::Primary biliary cirrhosis and primary sclerosing cholangitis share some clinical features with autoimmune hepatitis, but when features of autoimmune hepatitis are present, prognosis can be affected and immunosuppressive treatment warranted. The presence of severe interface hepatitis in primary biliary cirrhosis porten...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2012.12.006

    authors: Mayo MJ

    更新日期:2013-05-01 00:00:00

  • Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

    abstract::Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established procedure used in the management of complications of portal hypertension. Although the most robust evidence supports the use of TIPS as salvage therapy in variceal hemorrhage, secondary prophylaxis of variceal bleeding, and treatment of refract...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2019.07.004

    authors: Hung ML,Lee EW

    更新日期:2019-11-01 00:00:00

  • Epidemiology of nonalcoholic fatty liver.

    abstract::Nonalcoholic fatty liver (NAFL) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure. Because it is often asymptomatic,many people may not know that they have it. NAFL is closely linked to obesity, which in the United States and other developed coun...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.04.008

    authors: Ruhl CE,Everhart JE

    更新日期:2004-08-01 00:00:00

  • Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features.

    abstract::The diagnosis of AIH depends on the finding of several suggestive features together with careful exclusion of liver diseases of other etiologies. Wherever possible, the diagnosis should be confirmed histologically by an experienced hepatopathologist. Seronegativity for the conventional autoantibodies at presentation d...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00019-3

    authors: McFarlane IG

    更新日期:2002-08-01 00:00:00

  • Chronic hepatitis B: past, present, and future.

    abstract::There have been major advances in the field of hepatitis B (HBV) over the last few decades. These advances have resulted in the understanding of the natural history of chronic HBV infection, effective vaccines against the virus, sensitive assays for screening and monitoring of treatment, and effective treatments for v...

    journal_title:Clinics in liver disease

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.cld.2010.05.003

    authors: Lai M,Liaw YF

    更新日期:2010-08-01 00:00:00

  • The use of immunohistochemistry in liver tumors.

    abstract::A variety of benign and malignant neoplasms can be encountered in the liver. Hematoxylin and eosin-stained tissue sections alone may not yield sufficient information to definitively diagnose liver tumors; therefore, ancillary studies with immunohistochemical markers can play a crucial role in differentiating the diffe...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.10.001

    authors: Chan ES,Yeh MM

    更新日期:2010-11-01 00:00:00

  • Immunopathogenesis of hepatitis C virus infection.

    abstract::HCV infection becomes persistent in many patients who are otherwise immune competent. There is increasing support for potential contribution of innate immune response and viral interference with its components to the subsequent outcome. As for the adaptive immune response, humoral immunity may be largely ineffective d...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00068-5

    authors: Chang KM

    更新日期:2003-02-01 00:00:00

  • Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.

    abstract::Nonalcoholic fatty liver disease is emerging as the most common cause of chronic liver disease worldwide. This trend is, in part, secondary, to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome. Other risk factors include age, gender, race/ethnicity, genetic predisposition, and polycystic ovari...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.08.008

    authors: Lim HW,Bernstein DE

    更新日期:2018-02-01 00:00:00

  • Animal models of autoimmunity.

    abstract::Although several mouse models of AIH have been described, no model is ideal. Indeed, the disease is self-limited in each model, and none is associated with significant liver fibrosis or progression to cirrhosis. Nevertheless, these models should be useful for testing different hypotheses regarding the initiation of AI...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00026-0

    authors: Howell CD

    更新日期:2002-08-01 00:00:00

  • Chronic Hepatitis C Virus Infection and Depression.

    abstract::Hepatitis C virus (HCV) infection is a systemic disease with hepatic and extrahepatic manifestations, including neuropsychiatric conditions. Depression is a frequent disorder, which has been reported in one-third of patients with HCV infection and has an estimated prevalence of 1.5 to 4.0 times higher than that observ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.03.007

    authors: Adinolfi LE,Nevola R,Rinaldi L,Romano C,Giordano M

    更新日期:2017-08-01 00:00:00

  • Diagnostic issues in liver transplantation pathology.

    abstract::Liver biopsy is used to determine the pathogenesis of liver dysfunction after liver transplantation. One or more causative factors may be identified on biopsy. The pathologist must be familiar with the histopathology of acute rejection to differentiate it from other potential complications, including biliary obstructi...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00003-x

    authors: Lefkowitch JH

    更新日期:2002-05-01 00:00:00